Dow Up 0.36% Nasdaq Up 0.12%

More On SKP.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

SkyePharma plc (SKP.L)

-LSE
264.50 Up 15.25(6.12%) 8:08AM EDT
Prev Close:249.25
Open:250.00
Bid:263.75
Ask:264.50
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:249.75 - 264.50
52wk Range:78.00 - 266.00
Volume:133,483
Avg Vol (3m):429,661
Market Cap:121.70M
P/E (ttm):15,558.82
EPS (ttm):0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Headlines

  • No Headlines available for SKP.L at this time.

Key Statistics

Forward P/E (1 yr):0.11
P/S (ttm):183.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :15.00
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Skyepharma PLC, a drug delivery company, develops, manufactures, and sells oral and inhalation pharmaceutical products. Its marketed products include flutiform and ZYFLO CR for treating asthma; Relvar Ellipta/Breo Ellipta for asthma and COPD; Anor... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback